dopamine storage < dopamine transporter < dopamine transporter imaging

Facettes :

List of bibliographic references indexed by dopamine transporter

Number of relevant bibliographic references: 18.

Ident.	Authors (with country if any)	Title
000156 (2011)	Michael A. Schwarzschild [États-Unis] ; Kenneth Marek [États-Unis] ; Shirley Eberly [États-Unis] ; David Oakes [États-Unis] ; Ira Shoulson [États-Unis] ; Danna Jennings [États-Unis] ; John Seibyl [États-Unis] ; Alberto Ascherio [États-Unis]	Serum urate and probability of dopaminergic deficit in early “Parkinson's disease”
000519 (2010)	Y. K. Kim ; I-Y. Yoon ; J-M. Kim [Corée du Sud] ; S-H. Jeong ; K. W. Kim ; Y-K. Shin ; B. S. Kim ; S. E. Kim	The implication of nigrostriatal dopaminergic degeneration in the pathogenesis of REM sleep behavior disorder
000784 (2010)	K. Ishibashi [Japon] ; K. Kanemaru [Japon] ; Y. Saito [Japon] ; S. Murayama [Japon] ; K. Oda [Japon] ; K. Ishiwata [Japon] ; H. Mizusawa [Japon] ; K. Ishii [Japon]	Cerebrospinal fluid metabolite and nigrostriatal dopaminergic function in Parkinson’s disease
000D03 (2008)	Roberto Ceravolo [Italie] ; Angelo Antonini [Italie] ; Duccio Volterrani [Italie] ; Carlo Rossi [Italie] ; Lorenzo Kiferle [Italie] ; Daniela Frosini [Italie] ; Claudio Lucetti [Italie] ; Ioannis U. Isaias [Italie] ; Riccardo Benti [Italie] ; Luigi Murri [Italie] ; Ubaldo Bonuccelli [Italie]	Predictive value of nigrostriatal dysfunction in isolated tremor: A clinical and SPECT study
000D52 (2008)	Chun-Hung Lin ; Jui-Yen Huang [Taïwan] ; Cheng-Hsin Ching ; Jih-Ing Chuang [Taïwan]	Melatonin reduces the neuronal loss, downregulation of dopamine transporter, and upregulation of D2 receptor in rotenone‐induced parkinsonian rats
000F61 (2007)	Christoph Scherfler [Autriche] ; Johannes Schwarz [Allemagne] ; Angelo Antonini [Italie] ; Donald Grosset [Royaume-Uni] ; Francesc Valldeoriola [Espagne] ; Kenneth Marek [États-Unis] ; Wolfgang Oertel [Allemagne] ; Eduardo Tolosa [Espagne] ; Andrew Lees (neurologue) [Royaume-Uni] ; Werner Poewe [Autriche]	Role of DAT‐SPECT in the diagnostic work up of Parkinsonism
001482 (2005)	J. Eerola [Finlande] ; P J Tienari [Finlande] ; S. Kaakkola [Finlande] ; P. Nikkinen ; J. Launes [Finlande]	How useful is [123I]β-CIT SPECT in clinical practice?
001518 (2005)	K. Stiasny-Kolster ; Y. Doerr ; J. C. Mo Ller ; H. Ho Ffken ; T. M. Behr ; W. H. Oertel ; G. Mayer [Allemagne]	Combination of ‘idiopathic’ REM sleep behaviour disorder and olfactory dysfunction as possible indicator for α-synucleinopathy demonstrated by dopamine transporter FP-CIT-SPECT
001548 (2005)	J. Wang [République populaire de Chine] ; Y. Jiang [République populaire de Chine] ; X. Liu [République populaire de Chine] ; Z. Chen [République populaire de Chine] ; L. Yang [République populaire de Chine] ; C. Liu [République populaire de Chine] ; J. Xiang [République populaire de Chine] ; H. Su [République populaire de Chine]	99mTc‐TRODAT‐1 SPECT study in early Parkinson's disease and essential tremor
001713 (2003)	Vicky Marshall [Royaume-Uni] ; Donald Grosset [Royaume-Uni]	Role of dopamine transporter imaging in routine clinical practice
001714 (2003)	Werner Poewe [Autriche] ; Christoph Scherfler [Autriche]	Role of dopamine transporter imaging in investigation of parkinsonian syndromes in routine clinical practice
001795 (2003)	Walter Pirker [Autriche]	Correlation of dopamine transporter imaging with parkinsonian motor handicap: How close is it?
001904 (2002)	Y. Kim [Corée du Sud] ; J. Kim [Corée du Sud] ; J. Kim [Corée du Sud] ; C. Yoo [Corée du Sud] ; C. R. Lee [Corée du Sud] ; J. H. Lee [Corée du Sud] ; H. K. Kim [Corée du Sud] ; S. O. Yang [Corée du Sud] ; H. K. Chung [Corée du Sud] ; D. S. Lee [Corée du Sud] ; B. Jeon [Corée du Sud]	Dopamine transporter density is decreased in parkinsonian patients with a history of manganese exposure: What does it mean?
001908 (2002)	K. Marek [États-Unis] ; D. Jennings [États-Unis] ; J. Seibyl [États-Unis]	Do dopamine agonists or levodopa modify Parkinson's disease progression?
001923 (2002)	Yun J. Kim [Canada] ; Masanori Ichise [Canada] ; James R. Ballinger [Canada] ; Douglas Vines [Canada] ; Sean S. Erami [Canada] ; Tatsuro Tatschida [Canada] ; Anthony E. Lang [Canada]	Combination of dopamine transporter and D2 receptor SPECT in the diagnostic evaluation of PD, MSA, and PSP
001990 (2001)	Juha O. Rinne [Finlande] ; Elina Nurmi [Finlande] ; Hanna M. Ruottinen [Finlande] ; Jörgen Bergman [Finlande] ; Olli Eskola [Finlande] ; Olof Solin [Finlande]	[18F]FDOPA and [18F]CFT are both sensitive PET markers to detect presynaptic dopaminergic hypofunction in early Parkinson's disease
001991 (2001)	Tarja H. Haapaniemi [Finlande] ; Aapo Ahonen [Finlande] ; Pentti Torniainen [Finlande] ; Kyösti A. Sotaniemi [Finlande] ; Vilho V. Myllyl [Finlande]	[123I]β‐CIT SPECT demonstrates decreased brain dopamine and serotonin transporter levels in untreated parkinsonian patients
001B69 (2000)	Sophie Callier [Canada, France] ; Marc Morissette [Canada] ; Michelle Grbois [Canada] ; Thérèse Di Paolo [Canada]	Stereospecific prevention by 17β‐estradiol of MPTP‐induced dopamine depletion in mice

---

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/ParkinsonV1/Data/Main/Exploration

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/KwdEn.i -k "dopamine transporter" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/KwdEn.i  \
                -Sk "dopamine transporter" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    ParkinsonV1
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    KwdEn.i
   |clé=    dopamine transporter
}}

---

This area was generated with Dilib version V0.6.23. Data generation: Sun Jul 3 18:06:51 2016. Site generation: Wed Mar 6 18:46:03 2024